Finding sugar-coated proteins on heart cells to learn about heart disease

Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease

NIH-funded research University of Nebraska Medical Center · NIH-11323879

This project builds lab tools to find and measure sugar-linked proteins on heart cells to help make better stem-cell heart cells and improve care for people with heart failure.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center NIH-funded
Lab location1 site (Omaha, United States)
Project IDNIH-11323879 on NIH RePORTER

What this research studies

Researchers are developing advanced mass spectrometry and computer tools to spot proteins and sugars on the surface of heart cells. They work with small numbers of human cells, including lab-grown stem-cell cardiomyocytes and samples from healthy and failing human hearts. The team uses these markers to identify and sort mature heart cells and to map cell-type specific protein and sugar patterns in diseased hearts. The goal is to make more uniform stem-cell heart cells for research and future therapies and to discover ways to monitor and treat advanced heart failure.

Who could benefit from this research

Good fit: Ideal candidates would be people with heart disease—especially those with advanced heart failure undergoing procedures like transplant or device surgery who can donate small heart tissue samples for research.

Not a fit: People without heart disease or those who cannot or do not want to donate tissue are unlikely to receive direct benefit from participating in this project.

Why it matters

Potential benefit: If successful, this work could produce clearer biomarkers and purer stem-cell-derived heart cells that improve future monitoring and treatments for people with heart disease.

How similar studies have performed: Related mass-spectrometry and glycoproteomics research has identified useful heart cell markers, but applying these methods to stem-cell cardiomyocytes and failing human hearts is relatively new.

Where this research is happening

Omaha, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.